Product Information for Symbicort Rapihaler (budesonide ...

There was no statistical significant difference in time to first severe asthma exacerbation between the two treatment groups. COPD The efficacy and safety of Symbicort in the treatment of patients with moderate to severe COPD (pre-bronchodilator FEV 1 50% predicted normal) has been evaluated in four randomised, double-blind, placebo and active ... ................
................